InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
4
T+90 胜率
0%
T+90 平均收益
-49.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Elms Steve, 董事. Insider active across 4 companies, notably Marker Therapeutics, Inc.. In total, 14 disclosures have been published. Split: 2 buys · 4 sells. Total volume traded: €6.8m. Activity tracked since 8 June 2021. The latest transaction was disclosed on 5 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Elms Steve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
7,000 股@ US$15.671.4% 占其流量Common StockSEC:0001140361-26-008363:0
标准退出：2026年6月3日 (T+90)
10,690 股0Common StockSEC:0001140361-26-004885:0
92,941 股@ US$21.6925.9% 占其流量Common StockSEC:0001140361-25-022713:0
10,889 股0Common StockSEC:0001140361-25-005541:0
11,085 股@ US$3.20100.0% 占其流量Common StockSEC:0001104659-24-131704:0
标准退出：2025年3月23日 (T+90)
9,000 股@ US$10.801.9% 占其流量Common StockSEC:0001140361-24-048224:0
49,887 股@ US$6.015.5% 占其流量Common StockSEC:0001140361-24-014226:0
411,829 股@ US$6.0846.2% 占其流量Common StockSEC:0001140361-24-014226:1
407,000 股@ US$6.2146.4% 占其流量Common StockSEC:0001140361-24-013634:0
24,040 股0Common StockSEC:0001140361-24-010237:0
25,815 股0Common StockSEC:0001140361-23-010771:0
26,586 股0Common StockSEC:0001140361-22-008676:0
15,000 股0Common StockSEC:0001567619-21-012087:0
12,658 股0Common StockSEC:0001209191-21-039632:0
14 条申报中的 14 条
About Elms Steve
ELMS STEVE is an Administrateur at Adma Biologics, INC., Marker Therapeutics, Inc. and Zosano Pharma Corp. He has 14 filings in total, and across the sampled recent filings from 2021-06-10 to 2026-03-09, the reported aggregate amounts are EUR 128270 in buys and EUR 6628872 in sells, with the modal transaction nature listed as Attribution.
